Neuron-specific enolase level is a useful biomarker for distinguishing amyotrophic lateral sclerosis from cervical spondylotic myelopathy

The current study aimed to evaluate whether cerebrospinal fluid (CSF) neuron-specific enolase (NSE) levels are elevated in amyotrophic lateral sclerosis (ALS) and are effective in distinguishing ALS from cervical spondylotic myelopathy (CSM). We retrospectively evaluated 45 patients with ALS, 23 wit...

Descripción completa

Detalles Bibliográficos
Autores principales: Tsukahara, Akihiro, Hosokawa, Takafumi, Nishioka, Daisuke, Kotani, Takuya, Ishida, Shimon, Takeuchi, Tohru, Kimura, Fumiharu, Arawaka, Shigeki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8613178/
https://www.ncbi.nlm.nih.gov/pubmed/34819571
http://dx.doi.org/10.1038/s41598-021-02310-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8613178/
https://www.ncbi.nlm.nih.gov/pubmed/34819571
http://dx.doi.org/10.1038/s41598-021-02310-2

Ejemplares similares